Vice President, Collaborations, Collaborative Drug Discovery
Biography
Scott recently joined CDD to help refine and grow its new BioHarmony data services business. Scott has over 30 years of experience in the pharmaceutical research industry. His career has focused on the development and commercialization of informatics tools and services that improve the drug discovery & development process. Scott has served in multiple senior leadership roles including VP, GM at Tripos, Inc. a Computer Aided Molecular Design company, Co-Founder & CEO of ChemNavigator.com an online chemistry services company which was acquired by Sigma-Aldrich Inc., and Commercial Director of Elsevier Life Sciences Professional Services.
AI and Data Sciences Showcase:
Collaborative Drug Discovery
CDD advances science through better data management. It’s CDD Vault® product, is a hosted informatics solution that allows researchers to organize data and experiments and securely collaborate in real time. CDD also offers BioHarmony™ Drug Data Store and Annotator an ML assisted bioassay annotation platform.
ML Bioassay Annotation and FAIR Drug Data
FAIR Drug data and new ML technology for the automated curation and annotation of bioassay protocols.
Session Abstract – PMWC 2022 Silicon Valley
Track 7 - June 28 10.00 A.M.-1.15 P.M.,Track 7 - June 29 11.00 A.M.-1.15 P.M.,Track 7 - June 30 9.00 A.M.-11.15 A.M.
The PMWC 2022 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
